R. Cahen

1.1k total citations
37 papers, 568 citations indexed

About

R. Cahen is a scholar working on Epidemiology, Nephrology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, R. Cahen has authored 37 papers receiving a total of 568 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Epidemiology, 5 papers in Nephrology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in R. Cahen's work include Renal Transplantation Outcomes and Treatments (5 papers), Renal Diseases and Glomerulopathies (3 papers) and Radioactive element chemistry and processing (3 papers). R. Cahen is often cited by papers focused on Renal Transplantation Outcomes and Treatments (5 papers), Renal Diseases and Glomerulopathies (3 papers) and Radioactive element chemistry and processing (3 papers). R. Cahen collaborates with scholars based in France, United States and Switzerland. R. Cahen's co-authors include Pierre Trolliet, Pierre Loubeyre, Emmanuel Morélon, Claire Pouteil‐Noble, G. Brunisholz, M Labeeuw, Jean‐Louis Touraine, P. Boissonnat, B Parchoux and Laurent Sebbag and has published in prestigious journals such as PLoS ONE, Analytical Chemistry and Radiology.

In The Last Decade

R. Cahen

36 papers receiving 536 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. Cahen France 13 190 151 127 101 68 37 568
Michael Burke Australia 11 131 0.7× 138 0.9× 25 0.2× 57 0.6× 53 0.8× 22 610
Okechukwu Ojogho United States 16 134 0.7× 70 0.5× 193 1.5× 41 0.4× 227 3.3× 33 622
Barbara Andreetta Italy 14 51 0.3× 62 0.4× 92 0.7× 201 2.0× 132 1.9× 22 641
Michael J. Holman United States 21 292 1.5× 167 1.1× 66 0.5× 43 0.4× 412 6.1× 58 1.2k
Şahika Zeynep Akı Türkiye 17 141 0.7× 285 1.9× 92 0.7× 18 0.2× 45 0.7× 71 895
Sapna Shah United Kingdom 17 78 0.4× 116 0.8× 37 0.3× 107 1.1× 298 4.4× 52 1.0k
Mark Ethell United Kingdom 17 108 0.6× 279 1.8× 97 0.8× 25 0.2× 68 1.0× 44 952
Mika Nakamae Japan 12 66 0.3× 204 1.4× 67 0.5× 53 0.5× 38 0.6× 73 669
Kwaku Marfo United States 13 107 0.6× 81 0.5× 52 0.4× 108 1.1× 174 2.6× 31 675
M. E. SNELL United Kingdom 14 50 0.3× 81 0.5× 557 4.4× 49 0.5× 251 3.7× 38 945

Countries citing papers authored by R. Cahen

Since Specialization
Citations

This map shows the geographic impact of R. Cahen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Cahen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Cahen more than expected).

Fields of papers citing papers by R. Cahen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Cahen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Cahen. The network helps show where R. Cahen may publish in the future.

Co-authorship network of co-authors of R. Cahen

This figure shows the co-authorship network connecting the top 25 collaborators of R. Cahen. A scholar is included among the top collaborators of R. Cahen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Cahen. R. Cahen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kanitakis, Jean, et al.. (2018). Basal-Cell Carcinoma With Matrical Differentiation: Report of a New Case in a Renal-Transplant Recipient and Literature Review. American Journal of Dermatopathology. 40(8). e115–e118. 4 indexed citations
2.
Mazeron, Marie‐Christine, Gaëtan Ligat, Claire Pouteil‐Noble, et al.. (2016). Contrasting effect of new HCMV pUL54 mutations on antiviral drug susceptibility: Benefits and limits of 3D analysis. Antiviral Research. 129. 115–119. 18 indexed citations
3.
Buron, Fanny, Paolo Malvezzi, Emmanuel Villar, et al.. (2013). Profiling Sirolimus-Induced Inflammatory Syndrome: A Prospective Tricentric Observational Study. PLoS ONE. 8(1). e53078–e53078. 17 indexed citations
4.
Corre, Nicole Le, Claire Pouteil Noble, Vincent Meiffrédy, et al.. (2012). Effect of two injections of non-adjuvanted influenza A H1N1pdm2009 vaccine in renal transplant recipients: INSERM C09-32 TRANSFLUVAC trial. Vaccine. 30(52). 7522–7528. 24 indexed citations
5.
Labeeuw, M, Pierre Trolliet, R. Cahen, et al.. (2011). Confounding factors for early death in incident end‐stage renal disease patients: Role of emergency dialysis start. Hemodialysis International. 15(1). 23–29. 15 indexed citations
6.
Cahen, R., et al.. (2011). Reversible ileitis secondary to high dose intravenous immunoglobulin in adult kidney transplant patient treated for acute humoral rejection. Transplant International. 24(12). e111–e114. 1 indexed citations
7.
Cahen, R., et al.. (2010). Hémorragie sous-arachnoïdienne anévrismale et maladie de Wegener : une association peu commune. Neurochirurgie. 56(4). 331–336. 1 indexed citations
8.
Morélon, Emmanuel, Claire Pouteil Noble, R. Cahen, et al.. (2010). Immunogenicity and safety of intradermal influenza vaccination in renal transplant patients who were non-responders to conventional influenza vaccination. Vaccine. 28(42). 6885–6890. 42 indexed citations
9.
Trolliet, Pierre, et al.. (2009). The Impact of Type 2 Diabetes on Mortality in End-Stage Renal Disease Patients Differs between Genders. Nephron Clinical Practice. 112(4). c268–c275. 21 indexed citations
10.
Villar, Emmanuel, P. Boissonnat, Laurent Sebbag, et al.. (2007). Poor prognosis of heart transplant patients with end-stage renal failure. Nephrology Dialysis Transplantation. 22(5). 1383–1389. 20 indexed citations
11.
Euvrard, Sylvie, Jean Kanitakis, Évelyne Decullier, et al.. (2006). Subsequent Skin Cancers in Kidney and Heart Transplant Recipients after the First Squamous Cell Carcinoma. Transplantation. 81(8). 1093–1100. 120 indexed citations
12.
Loubeyre, Pierre, et al.. (1997). Transplanted renal artery: detection of stenosis with color Doppler US.. Radiology. 203(3). 661–665. 36 indexed citations
13.
Loubeyre, Pierre, et al.. (1996). MR angiography of renal artery stenosis: value of the combination of three-dimensional time-of-flight and three-dimensional phase-contrast MR angiography sequences.. American Journal of Roentgenology. 167(2). 489–494. 53 indexed citations
14.
Cahen, R., et al.. (1996). Magnetic resonance angiography for the detection of transplant renal artery stenosis.. PubMed. 28(5). 2830–2830. 2 indexed citations
15.
Cahen, R., et al.. (1995). Automated renal transplant biopsy with real-time ultrasonic guidance.. PubMed. 27(2). 1729–30. 4 indexed citations
16.
Cahen, R., et al.. (1994). Creatinine Metabolism Impairment by an Anticonvulsant Drug, Phenacemide. Annals of Pharmacotherapy. 28(1). 49–51. 2 indexed citations
17.
Cahen, R., et al.. (1989). Aetiology of Membranous Glomerulonephritis: A Prospective Study of 82 Adult Patients. Nephrology Dialysis Transplantation. 4(3). 172–180. 57 indexed citations
18.
François, Bruno, et al.. (1982). [Is the serum level of beta 2 microglobulin a better marker of glomerular filtration than blood creatinine?].. PubMed. 3(3). 116–8. 1 indexed citations
19.
Cahen, R., et al.. (1964). RECHERCHE DE L'EFFET T'ERATOG'ENE DE LA 2-DI'ETHYLAMINOPROPIOPH'ENONE.. 10. 1 indexed citations
20.
Cahen, R., et al.. (1963). [Pharmacological study of dihydroxyaluminum allantoinate and chlorhydroxyaluminum allantoinate. IV. Effect on experimental drug-induced ulcer].. PubMed. 21. 215–22. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael Burke Breakdown of academic impact, for papers by Okechukwu Ojogho Breakdown of academic impact, for papers by Barbara Andreetta Breakdown of academic impact, for papers by Michael J. Holman Breakdown of academic impact, for papers by Şahika Zeynep Akı Breakdown of academic impact, for papers by Sapna Shah Breakdown of academic impact, for papers by Mark Ethell Breakdown of academic impact, for papers by Mika Nakamae Breakdown of academic impact, for papers by Kwaku Marfo Breakdown of academic impact, for papers by M. E. SNELL
Rankless by CCL
2026